Health Condition 1: J353- Hypertrophy of tonsils with hypertrophy of adenoids
Conditions
Interventions
Intervention1: Individualized Homoeopathic Medicine: Intervention is planned as administrating the indicated homoeopathic medicines. Selection of medicine, potency and dosage will be according to ho
Sponsors
Dr Debmoy Nandi
Eligibility
Inclusion criteria
Inclusion criteria: 1.Children aged 4 18 years presenting with primary nasal symptoms, with or without accompanying ear symptoms. 2.Children with adenotonsillar hypertrophy for whom surgery is contraindicated. 3.Children with tonsillar hypertrophy as established by physical examination and/or medical history, including those with obstructive sleep apnea syndrome (OSAS) and snoring. 4.Children with recurrent or chronic rhinosinusitis (persistent, non-responsive to standard medical treatment) attributed to adenoid hypertrophy blocking nasal or sinus drainage pathways. 5.Children with severe dysphagia (difficulty swallowing), especially where a swallow evaluation indicates significantly impaired food intake due to enlarged tonsils. 6.Patients of all sexes, religions, and socioeconomic backgrounds. 7.Parents (or legal guardians) willing to provide written informed consent for participation in the study; children aged 7 12 years must provide verbal assent, while those aged 12 17 years must provide written assent. 8.Patients or parents/guardians who can read, write, or understand English, Hindi, or Bengali.
Exclusion criteria
Exclusion criteria: 1. Adenotonsillar hypertrophy with moderate to severe conductive deafness, gross septal deviation. 2. Evidence of malignancy (e.g., lymphoma of the tonsils/adenoids): While rare, any suspicion or confirmed diagnosis of neoplastic conditions affecting the tonsils or adenoids would necessitate exclusion, as their management pathway is entirely different. 3. Co-existing neuromuscular disorders: Children with conditions like cerebral palsy, muscular dystrophy, or other neuromuscular diseases that affect airway patency or swallowing function are typically excluded, as their symptoms and management are often distinct. 4. Cases with substance abuse or any psychiatric illness. 5. Active acute infections at the time of assessment/enrollment: Children presenting with an acute tonsillitis flare-up, pharyngitis, or other severe respiratory infections that might temporarily exacerbate symptoms and not reflect chronic adenotonsillar hypertrophy. 6. History of prior adenoidectomy and/or tonsillectomy: If the research is about primary management or characteristics of adenotonsillar hypertrophy, children who have already undergone these procedures would be excluded to avoid confounding variables related to previous interventions. 7. Congenital anomaly, critically ill and immune-compromised patients. 8. Children suffering from uncontrolled systemic diseases. 9. Simultaneous participation in any other clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Friedman Tonsil Grading 2. The adenoid/nasopharyngeal(A/N) ratio was evaluated through lateral cephalometric radiographic assessmentTimepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| TAHSI questionnairesTimepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr Mahua Majumder
The calcutta homoeopathic medical college and hospital
Outcome results
None listed